Phase I Trial of Chemoimmunotherapy and Hypofractionated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.
Phase of Trial: Phase I
Latest Information Update: 05 Feb 2018
Price : $35 *
At a glance
- Drugs Gemcitabine (Primary) ; Tadalafil (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- Acronyms CRIT
- 31 Jan 2018 Status changed from active, no longer recruiting to completed.
- 03 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
- 03 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.